News
10 April 2025 Decision overturns earlier decision allowing generic drug maker to launch version | Dispute centres on ...
Prompter patent issue will provide earlier protection for inventions and could avoid need for Quick Path Information ...
Massachusetts lawsuit claims subsidiary of UK pharma company unlawfully re-patented eculizumab, resulting in overpayments of ...
Texas company launches sweeping lawsuits against five major players, alleging infringement of medical device patents tied to ...
A new High Court judge will be tasked with the “massive decision” on the plausibility of Bristol Myers Squibb’s key anticoagulant patent, following its appeal over failures in the previous trial, say ...
Firm’s chair says Fenwick has been active in market for a long time and “waiting to find the right opportunity to deepen our bench and presence”.
AstraZeneca fends off diabetes generic, for now ...
Court hears arguments from J&J and Teva to determine whether a patent blocking generic versions of Invega Sustenna will be upheld | J&J fights to protect its last remaining Orange Book patent covering ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results